There were 1,674 press releases posted in the last 24 hours and 426,514 in the last 365 days.

Medical Biomimetics Market to Surpass US$ 43.4 Bn globally by end of 2027, Says CMI

SEATTLE, April 20, 2020 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global medical biomimetics market was valued at US$ 26.2 billion in 2019, and is projected to exhibit a CAGR of 6.5% over the forecast period (2020–2027).

Key Trends and Analysis of the Global Medical Biomimetics Market:

Key trends in market are the rising incidence of breast cancer, cardiovascular disorders, increasing product approvals, and large potential in emerging economies is expected to fuel the growth of the medical biomimetics market.

According to, around 250,000 cases of invasive breast cancer are expected to be diagnosed in the U.S. in 2017, along with 60,000 cases of non-invasive breast cancer. This is projected to create a highly conducive environment for the growth of the global medical biomimetics market in the near future.

Request for Sample PDF copy @

Furthermore, the growing population in emerging economies such as India, and the increasing focus of regional governments on strengthening the healthcare infrastructure are expected to drive growth of the global medical biomimetics market in the near future. For instance, according to a report published by the India Brand Equity Foundation in 2019, the healthcare expenditure in India increased to 1.4% in 2018 compared to 1.2% in 2012. The report also suggested that the government of India is planning to increase public health spending to 2.5% of the country's GDP by 2025.

Key Market Takeaways:

  • The global medical biomimetics market is expected to exhibit a CAGR of 6.5% during the forecast period (2020–2027) owing to the increasing incidence of chronic diseases in developing and developed economies of the world, as well as research regarding the use of biomimetics in ophthalmology and the rising healthcare expenditure. For instance, in 2019, researchers from the University of California conducted a study on the use of biomemetics in ophthalmology for neuromuscular oculomotor control.
  • Key players in the market are focused on development of new products and strategic collaborations to expand their product portfolio which is expected to propel the market growth during the forecast period. For instance, in 2016, AVINENT Science and Technology launched the new Biomimetic PEARL mini implant, a minimally invasive solution for removable prosthesis.

Read Report Summary @

Key players operating in the global medical biomimetics market are—

AVINENT Science and Technology, SynTouch Inc., Wright Medical Group N.V., EP Endovascular AB, Varian Medical Systems, Inc., Abbott, Osteopore International Pte Ltd., and Applied Biomimetic

Market Segmentation:

  • Global Medical Biomimetics Market, By Product Type:
    • Cardiovascular
    • Ophthalmology
    • Dental
    • Orthopedic
    • Others
  • Global Medical Biomimetics Market, By Application:
    • Wound Healing
    • Plastic Surgery
    • Drug Delivery
    • Others
  • Global Medical Biomimetics Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa

Buy this Research Report @

Did not find what you were looking for? Here are some similar topics:


The major factors driving growth of the continuous glucose monitoring devices market include rapid technological advancement in CGM devices along with increasing adoption of inorganic growth strategies such as collaborations and agreements to develop novel CGM devices in the market is expected to drive the market growth over the forecast period. For instance, in September 2019, Medtronic Plc. collaborated with Novo Nordisk to provide integrated digital solutions for people with diabete

Read more @


Wound debridement involves removal of dead, infected or damaged tissue to accelerate healing process of the remaining healthy tissue. There are several devices available in the market for wound debridement. For instance, devices such as mechanical pads, Hydrosurgical Debridement Devices, Low Frequency Ultrasound Devices, Traditional Wound Debridement Devices, and others are used for wound debridement.

Read more @


Neonatal Infant Care Equipment are used for monitoring infant medical conditions such as low birth weight and premature birth. Neonatal equipment comprises of heart or cardiorespiratory monitor, blood pressure monitor, temperature probe, pulse oximeter, and others.

Read more @

Mr. Shah
Coherent Market Insights
1001 4th Ave. 
Seattle, WA 98154
Tel: +1-206-701-6702

Primary Logo